Cargando…

Anlotinib suppresses lung adenocarcinoma growth via inhibiting FASN-mediated lipid metabolism

BACKGROUND: Anlotinib, a vascular endothelial growth factor receptor (VEGFR) inhibitor, has been widely used in advanced lung cancer patients, but the intrinsic mechanism of cancer cell elimination is not fully disclosed. In this study, we reported that anlotinib suppressed lung adenocarcinoma (LUAD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Juan, Huang, Jie, Huang, Yu, Chen, Yidan, Li, Jiawei, Luo, Peihua, Zhang, Qianyun, Qiu, Yao, Wang, Lie, Jiang, Hong, Ma, Shenglin, Chen, Xueqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843377/ https://www.ncbi.nlm.nih.gov/pubmed/36660682 http://dx.doi.org/10.21037/atm-22-5438

Ejemplares similares

Multi-omics analysis identifies potential mechanisms of AURKB in mediating poor outcome of lung adenocarcinoma
por: Huang, Jie, et al.
Publicado: (2021)

FASN-Mediated Lipid Metabolism Regulates Goose Granulosa Cells Apoptosis and Steroidogenesis
por: Chen, Xi, et al.
Publicado: (2020)

FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma
por: Chianese, Ugo, et al.
Publicado: (2023)

CircRREB1 mediates lipid metabolism related senescent phenotypes in chondrocytes through FASN post-translational modifications
por: Gong, Zhe, et al.
Publicado: (2023)

TRIM21 ameliorates hepatic glucose and lipid metabolic disorders in type 2 diabetes mellitus by ubiquitination of PEPCK1 and FASN
por: Zhang, Kaini, et al.
Publicado: (2023)

Pemetrexed-Platinum With or Without Bevacizumab for Chinese Chemo-Naive Advanced Lung Adenocarcinoma Patients: A Real-World Study
por: Li, Xin, et al.
Publicado: (2021)

Prenatal caloric restriction alters lipid metabolism but not hepatic Fasn gene expression and methylation profiles in rats
por: Nowacka-Woszuk, Joanna, et al.
Publicado: (2017)

Enhanced De Novo Lipid Synthesis Mediated by FASN Induces Chemoresistance in Colorectal Cancer
por: Han, Lingyu, et al.
Publicado: (2023)

Metformin alleviates inflammation through suppressing FASN-dependent palmitoylation of Akt
por: Xiong, Wenfang, et al.
Publicado: (2021)

Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth
por: Han, Anna, et al.
Publicado: (2023)

Anlotinib affects systemic lipid metabolism and induces lipid accumulation in human lung cancer cells
por: Zhu, Zhongling, et al.
Publicado: (2023)

Identification of Acetylation Sites of Fatty Acid Synthase (FASN) by Mass Spectrometry and FASN Activity Assay
por: Miao, Ting, et al.
Publicado: (2023)

KDM5C Represses FASN-Mediated Lipid Metabolism to Exert Tumor Suppressor Activity in Intrahepatic Cholangiocarcinoma
por: Zhang, Bo, et al.
Publicado: (2020)

Alveolar type II epithelial cell FASN maintains lipid homeostasis in experimental COPD
por: Fan, Li-Chao, et al.
Publicado: (2023)

FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β‐catenin pathway
por: Lu, Feiyu, et al.
Publicado: (2023)

Resensitizing Paclitaxel-Resistant Ovarian Cancer via Targeting Lipid Metabolism Key Enzymes CPT1A, SCD and FASN
por: Ma, Qinsiyu, et al.
Publicado: (2023)

FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression
por: Ye, Mujie, et al.
Publicado: (2023)

The fasn-1(g14ts) allele is a Gly1830Arg missense mutation in C. elegans FASN-1
por: Bai, Xiaofei, et al.
Publicado: (2020)

FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesis
por: Du, Qiqiao, et al.
Publicado: (2022)

Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway
por: Chang, Ligong, et al.
Publicado: (2019)

Alpinumisoflavone Exhibits the Therapeutic Effect on Prostate Cancer Cells by Repressing AR and Co-Targeting FASN- and HMGCR-Mediated Lipid and Cholesterol Biosynthesis
por: Basavaraj, Praveenkumar, et al.
Publicado: (2022)

Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling
por: Qin, Tingting, et al.
Publicado: (2020)

The effect of FASN inhibition on the growth and metabolism of a cisplatin‐resistant ovarian carcinoma model
por: Papaevangelou, Efthymia, et al.
Publicado: (2018)

Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib
por: Tang, Mengqiu, et al.
Publicado: (2021)

A FASN-TGF-β1-FASN regulatory loop contributes to high EMT/metastatic potential of cisplatin-resistant non-small cell lung cancer
por: Yang, Li, et al.
Publicado: (2016)

CircRNA MBOAT2 promotes intrahepatic cholangiocarcinoma progression and lipid metabolism reprogramming by stabilizing PTBP1 to facilitate FASN mRNA cytoplasmic export
por: Yu, Xiaopeng, et al.
Publicado: (2023)

MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression
por: Duan, Jiangman, et al.
Publicado: (2017)

Efficacy and Safety of Anlotinib Combined with Liposomal Doxorubicin Followed by Anlotinib Maintenance in Metastatic Soft Tissue Sarcomas
por: Liu, Zhiyong, et al.
Publicado: (2021)

FASN activity is important for the initial stages of the induction of senescence
por: Fafián-Labora, Juan, et al.
Publicado: (2019)

SREBP1/FASN/cholesterol axis facilitates radioresistance in colorectal cancer
por: Jin, Yuxiao, et al.
Publicado: (2021)

Integrated Transcriptome and Metabolome Analysis Reveals the Regulatory Mechanisms of FASN in Geese Granulosa Cells
por: Chen, Xi, et al.
Publicado: (2022)

Anlotinib plus nab-paclitaxel/gemcitabine as first-line treatment prolongs survival in patients with unresectable or metastatic pancreatic adenocarcinoma: a retrospective cohort
por: Wu, Hongyang, et al.
Publicado: (2022)

Variation in the Fatty Acid Synthase Gene (FASN) and Its Association with Milk Traits in Gannan Yaks
por: Shi, Bingang, et al.
Publicado: (2019)

MAPK/P53-mediated FASN expression in bone tumors
por: Jiang, Ye, et al.
Publicado: (2017)

Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma
por: Sun, Tianhao, et al.
Publicado: (2019)

FASN-dependent de novo lipogenesis is required for brain development
por: Gonzalez-Bohorquez, Daniel, et al.
Publicado: (2022)

α-Lipoic Acid Alleviates Hepatic Lipid Deposition by Inhibiting FASN Expression via miR-3548 in Rats
por: Guo, Shihui, et al.
Publicado: (2021)

METTL3 suppresses anlotinib sensitivity by regulating m(6)A modification of FGFR3 in oral squamous cell carcinoma
por: Chen, Jie, et al.
Publicado: (2022)

Safety and Efficacy of Chemotherapy Combined with Anlotinib Plus Anlotinib Maintenance in Chinese Patients with Advanced/Metastatic Soft Tissue Sarcoma
por: Wang, Hai-ying, et al.
Publicado: (2020)

Antitumor effects of anlotinib in thyroid cancer
por: Ruan, Xianhui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e78vho6mqs0l4nq71bh8paien3